Advanced

AJNR - American Journal of Neuroradiology

Published ahead of print on February 26, 2009
doi: 10.3174/ajnr.A1519

This Article Free to Access Full Text Full Text (PDF) All Versions of this Article: ajnr.A1519v1 ajnr.A1519v2 30/6/1203    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kallmes, D.F. Articles by Jarvik, J.G. Search for Related Content PubMed PubMed Citation Articles by Kallmes, D.F. Articles by Jarvik, J.G.

American Journal of Neuroradiology 30:1203-1205, June-July 2009
© 2009 American Society of Neuroradiology

SPINE

Baseline Pain and Disability in the Investigational Vertebroplasty Efficacy and Safety Trial

D.F. Kallmes^a, B.A. Comstock^b,c, L.A. Gray^a, P.J. Heagerty^b,c, W. Hollingworth^f, J.A. Turner^b,d, L. Stout^b and J.G. Jarvik^b,e

^a Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minn
^b Data Coordinating Center Comparative Effectiveness, Cost and Outcomes Research, University of Washington, Seattle, Wash
^c Center for Biomedical Statistics, University of Washington, Seattle, Wash
^d Departments of Psychiatry and Behavioral Sciences and Rehabilitation Medicine, University of Washington, Seattle, Wash
^e Departments of Radiology, Neurosurgery, and Health Services, University of Washington, Seattle, Wash
^f Department of Social Medicine, University of Bristol, Bristol, UK

Please address correspondence to David F. Kallmes, MD, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: Kallmes.david{at}mayo.edu

BACKGROUND AND PURPOSE: Multiple case series of vertebroplasty outcomes have been published, though no large, placebo controlled trial has yet been performed. Our aim was to report baseline characteristics for the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST), a randomized blinded controlled study of vertebroplasty.

MATERIALS AND METHODS: We compared baseline demographics, pain scores, and scores on the modified Roland-Morris Disability Scale (RMDS), a back pain–specific metric, between 2 groups. One group included subjects enrolled at the lead INVEST site (n = 27 to date). The second group consisted of eligible patients seen concurrently at the lead INVEST site, who declined enrollment (n = 70). Comparisons were made by using 2-sample t tests.

RESULTS: Mean ages were similar between groups, averaging approximately 74 years among study participants and 77 years among nonenrolled eligible patients (P = .17). Approximately 75% of subjects were female in both groups. RMDS scores of enrolled patients at the lead site (18.0 ± 4.2) were not statistically different from those of eligible nonenrolled patients at the lead site (18.6 ± 3.6, P = .49). Pain scores in the enrolled subjects were measured as "average intensity over the prior 24 hours" with mean scores of 7.6 ± 2.1 among enrolled patients at the lead site. Pain scores in eligible nonenrolled patients were measured as "pain at rest," with mean score of 3.4 ± 3.3, and "pain with activity," with mean score of 8.5 ± 2.0.

CONCLUSIONS: Patient demographics among subjects enrolled in the INVEST are similar to those in a cohort of eligible nonenrolled patients. Back pain–specific disability was similar between subjects enrolled in the INVEST study and eligible nonenrolled patients at the lead site.

This article has been cited by other articles:

				W. Clark, S. Lyon, J. Burnes, M. O. Baerlocher, P. L. Munk, D. M. Liu, J. C. Lotz, A. Grey, M. Bolland, R. Buchbinder, et al. Trials of Vertebroplasty for Vertebral Fractures N. Engl. J. Med., November 19, 2009; 361(21): 2097 - 2100. [Full Text] [PDF]